Side Chain-Modified Benzothiazinone Derivatives with Anti-Mycobacterial Activity

被引:3
作者
Fan, Dongguang [1 ]
Wang, Bin [2 ]
Stelitano, Giovanni [3 ]
Savkova, Karin [4 ]
Riabova, Olga [5 ]
Shi, Rui [1 ]
Wu, Xiaomei [1 ]
Chiarelli, Laurent R. [3 ]
Mikusova, Katarina [4 ]
Makarov, Vadim [5 ]
Lu, Yu [2 ]
Hong, Yuzhi [6 ,7 ]
Qiao, Chunhua [1 ,7 ]
机构
[1] Soochow Univ, Coll Pharmaceut Sci, Suzhou 215123, Peoples R China
[2] Beijing Chest Hosp, Dept Pharmacol, Beijing Key Lab Drug Resistance TB Res, Beijing TB & Thorac Tumor Res, Beijing 101149, Peoples R China
[3] Univ Pavia, Dept Biol & Biotechnol, I-27100 Pavia, Italy
[4] Comenius Univ, Fac Nat Sci, Dept Biochem, Bratislava 84215, Slovakia
[5] Russian Acad Sci, Res Ctr Biotechnol, Moscow 119071, Russia
[6] Soochow Univ, Inst Mol Enzymol, Suzhou Med Coll, Sch Biol & Basic Med Sci, Suzhou 215123, Peoples R China
[7] Soochow Univ, Suzhou Med Coll, Suzhou Key Lab Pathogen Biosci & Antiinfect Med, Suzhou 215123, Peoples R China
基金
中国国家自然科学基金;
关键词
anti-tubercular agents; DprE1; inhibitor; structure activity relationship; in vivo activity; TUBERCULOSIS;
D O I
10.3390/biomedicines11071975
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Tuberculosis (TB) is a leading infectious disease with serious antibiotic resistance. The benzothiazinone (BTZ) scaffold PBTZ169 kills Mycobacterium tuberculosis (Mtb) through the inhibition of the essential cell wall enzyme decaprenylphosphoryl-& beta;-D-ribose 2'-oxidase (DprE1). PBTZ169 shows anti-TB potential in animal models and pilot clinical tests. Although highly potent, the BTZ type DprE1 inhibitors in general show extremely low aqueous solubility, which adversely affects the drug-like properties. To improve the compounds physicochemical properties, we generated a series of BTZ analogues. Several optimized compounds had MIC values against Mtb lower than 0.01 & mu;M. The representative compound 37 displays improved solubility and bioavailability compared to the lead compound. Additionally, compound 37 shows Mtb-killing ability in an acute infection mouse model.
引用
收藏
页数:18
相关论文
共 21 条
[1]   Structural and Activity Relationships of 6-Sulfonyl-8-Nitrobenzothiazinones as Antitubercular Agents [J].
Fan, Dongguang ;
Wang, Bin ;
Stelitano, Giovanni ;
Savkova, Karin ;
Shi, Rui ;
Huszar, Stanislav ;
Han, Quanquan ;
Mikusova, Katarina ;
Chiarelli, Laurent R. ;
Lu, Yu ;
Qiao, Chunhua .
JOURNAL OF MEDICINAL CHEMISTRY, 2021, 64 (19) :14526-14539
[2]   Applications of Fluorine in Medicinal Chemistry [J].
Gillis, Eric P. ;
Eastman, Kyle J. ;
Hill, Matthew D. ;
Donnelly, David J. ;
Meanwell, Nicholas A. .
JOURNAL OF MEDICINAL CHEMISTRY, 2015, 58 (21) :8315-8359
[3]   Development of 3,5-Dinitrophenyl-Containing 1,2,4-Triazoles and Their Trifluoromethyl Analogues as Highly Efficient Antitubercular Agents Inhibiting Decaprenylphosphoryl-β-D-ribofuranose 2′-Oxidase [J].
Karabanovich, Galina ;
Dusek, Jan ;
Savkova, Karin ;
Pavlis, Oto ;
Pavkova, Ivona ;
Korabecny, Jan ;
Kucera, Tomas ;
Vlckova, Hana Kocova ;
Huszar, Stanislav ;
Konyarikova, Zuzana ;
Konecna, Klara ;
Jand'ourek, Ondrej ;
Stolarikova, Jirina ;
Kordulakova, Jana ;
Vavrova, Katerina ;
Pavek, Petr ;
Klimesova, Vera ;
Hrabalek, Alexandr ;
Mikusova, Katarina ;
Roh, Jaroslav .
JOURNAL OF MEDICINAL CHEMISTRY, 2019, 62 (17) :8115-8139
[4]   Amide Bond Bioisosteres: Strategies, Synthesis, and Successes [J].
Kumari, Shikha ;
Carmona, Angelica, V ;
Tiwari, Amit K. ;
Trippier, Paul C. .
JOURNAL OF MEDICINAL CHEMISTRY, 2020, 63 (21) :12290-12358
[5]   Design, synthesis and evaluation of covalent inhibitors of DprE1 as antitubercular agents [J].
Liu, Lingfeng ;
Kong, Chengcheng ;
Fumagalli, Marco ;
Savkova, Karin ;
Xu, Yiwen ;
Huszar, Stanislav ;
Sammartino, Jose C. ;
Fan, Dongguang ;
Chiarelli, Laurent R. ;
Mikusova, Katarina ;
Sun, Zhaogang ;
Qiao, Chunhua .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2020, 208
[6]  
Makarov V., 2012, Patent No. [WO2012/066518A1, 2012066518]
[7]   Development of Macozinone for TB treatment: An Update [J].
Makarov, Vadim ;
Mikusova, Katarina .
APPLIED SCIENCES-BASEL, 2020, 10 (07)
[8]   Towards a new combination therapy for tuberculosis with next generation benzothiazinones [J].
Makarov, Vadim ;
Lechartier, Benoit ;
Zhang, Ming ;
Neres, Joao ;
van der Sar, Astrid M. ;
Raadsen, Susanne A. ;
Hartkoorn, Ruben C. ;
Ryabova, Olga B. ;
Vocat, Anthony ;
Decosterd, Laurent A. ;
Widmer, Nicolas ;
Buclin, Thierry ;
Bitter, Wilbert ;
Andries, Koen ;
Pojer, Florence ;
Dyson, Paul J. ;
Cole, Stewart T. .
EMBO MOLECULAR MEDICINE, 2014, 6 (03) :372-383
[9]   Benzothiazinones Kill Mycobacterium tuberculosis by Blocking Arabinan Synthesis [J].
Makarov, Vadim ;
Manina, Giulia ;
Mikusova, Katarina ;
Moellmann, Ute ;
Ryabova, Olga ;
Saint-Joanis, Brigitte ;
Dhar, Neeraj ;
Pasca, Maria Rosalia ;
Buroni, Silvia ;
Lucarelli, Anna Paola ;
Milano, Anna ;
De Rossi, Edda ;
Belanova, Martina ;
Bobovska, Adela ;
Dianiskova, Petronela ;
Kordulakova, Jana ;
Sala, Claudia ;
Fullam, Elizabeth ;
Schneider, Patricia ;
McKinney, John D. ;
Brodin, Priscille ;
Christophe, Thierry ;
Waddell, Simon ;
Butcher, Philip ;
Albrethsen, Jakob ;
Rosenkrands, Ida ;
Brosch, Roland ;
Nandi, Vrinda ;
Bharath, Sowmya ;
Gaonkar, Sheshagiri ;
Shandil, Radha K. ;
Balasubramanian, Venkataraman ;
Balganesh, Tanjore ;
Tyagi, Sandeep ;
Grosset, Jacques ;
Riccardi, Giovanna ;
Cole, Stewart T. .
SCIENCE, 2009, 324 (5928) :801-804
[10]   Structural Basis for Benzothiazinone-Mediated Killing of Mycobacterium tuberculosis [J].
Neres, Joao ;
Pojer, Florence ;
Molteni, Elisabetta ;
Chiarelli, Laurent R. ;
Dhar, Neeraj ;
Boy-Roettger, Stefanie ;
Buroni, Silvia ;
Fullam, Elizabeth ;
Degiacomi, Giulia ;
Lucarelli, Anna Paola ;
Read, Randy J. ;
Zanoni, Giuseppe ;
Edmondson, Dale E. ;
De Rossi, Edda ;
Pasca, Maria Rosalia ;
McKinney, John D. ;
Dyson, Paul J. ;
Riccardi, Giovanna ;
Mattevi, Andrea ;
Cole, Stewart T. ;
Binda, Claudia .
SCIENCE TRANSLATIONAL MEDICINE, 2012, 4 (150)